IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MAGRINI, STEFANO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.250
AS - Asia 11.514
EU - Europa 9.333
SA - Sud America 2.568
AF - Africa 269
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 21
Totale 43.980
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.896
CN - Cina 3.947
SG - Singapore 3.785
UA - Ucraina 2.339
BR - Brasile 2.174
HK - Hong Kong 1.572
IT - Italia 1.406
DE - Germania 1.403
FR - Francia 819
FI - Finlandia 740
VN - Vietnam 728
IE - Irlanda 549
PL - Polonia 549
RU - Federazione Russa 471
GB - Regno Unito 469
TR - Turchia 440
IN - India 263
BD - Bangladesh 230
CA - Canada 171
AR - Argentina 147
SE - Svezia 126
NL - Olanda 104
IQ - Iraq 101
MX - Messico 100
ZA - Sudafrica 83
EC - Ecuador 80
ID - Indonesia 77
EE - Estonia 65
JP - Giappone 57
CZ - Repubblica Ceca 55
CO - Colombia 44
UZ - Uzbekistan 44
ES - Italia 40
PK - Pakistan 40
VE - Venezuela 39
MA - Marocco 38
SA - Arabia Saudita 35
BE - Belgio 32
PY - Paraguay 32
AT - Austria 31
TN - Tunisia 27
EG - Egitto 24
NG - Nigeria 24
EU - Europa 23
KE - Kenya 22
GR - Grecia 20
NP - Nepal 20
JO - Giordania 19
CL - Cile 18
AU - Australia 17
LT - Lituania 17
AZ - Azerbaigian 16
IL - Israele 16
AE - Emirati Arabi Uniti 14
PE - Perù 14
DO - Repubblica Dominicana 13
JM - Giamaica 13
MY - Malesia 13
OM - Oman 12
PA - Panama 12
DZ - Algeria 11
SN - Senegal 11
BY - Bielorussia 10
CH - Svizzera 10
HN - Honduras 10
AL - Albania 9
BG - Bulgaria 9
BO - Bolivia 9
IR - Iran 9
KG - Kirghizistan 9
KZ - Kazakistan 9
PH - Filippine 9
UY - Uruguay 9
CR - Costa Rica 8
DK - Danimarca 8
HU - Ungheria 8
TT - Trinidad e Tobago 8
LA - Repubblica Popolare Democratica del Laos 7
LV - Lettonia 7
PT - Portogallo 7
TH - Thailandia 7
ET - Etiopia 6
KW - Kuwait 6
LB - Libano 6
MU - Mauritius 6
BB - Barbados 5
RS - Serbia 5
GT - Guatemala 4
KR - Corea 4
MK - Macedonia 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UG - Uganda 4
AO - Angola 3
CI - Costa d'Avorio 3
KH - Cambogia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
AM - Armenia 2
Totale 43.937
Salva come PNG Salva come JPEG
Città #
Singapore 1.949
Jacksonville 1.783
Ashburn 1.758
Fairfield 1.744
Woodbridge 1.608
Hong Kong 1.567
Houston 1.169
Ann Arbor 899
Princeton 806
Chandler 805
Cambridge 777
The Dalles 770
San Jose 748
Beijing 735
Wilmington 703
Seattle 699
Nanjing 579
Dublin 545
Warsaw 539
New York 470
Los Angeles 422
Lauterbourg 374
Helsinki 372
Istanbul 366
Dearborn 268
Ho Chi Minh City 243
Dallas 239
Nanchang 219
Buffalo 216
Des Moines 202
Milan 200
Moscow 198
São Paulo 196
Munich 171
Changsha 152
Brescia 149
Shenyang 139
Hanoi 131
Hebei 125
San Diego 121
Tianjin 120
Shanghai 118
Jinan 117
San Francisco 106
Orem 94
Council Bluffs 92
Jiaxing 89
Chicago 76
Redondo Beach 76
Rio de Janeiro 75
Santa Clara 71
Kunming 65
London 65
Tallinn 65
Rome 64
Verona 64
Hangzhou 61
Dong Ket 56
Boardman 50
Montreal 50
Tokyo 50
Washington 50
Turku 48
Zhengzhou 48
Brooklyn 47
Brasília 46
Nuremberg 46
Frankfurt am Main 45
Toronto 45
Belo Horizonte 44
Denver 44
Guangzhou 44
Chennai 43
Tashkent 40
Lancaster 39
Johannesburg 38
Brno 37
Quito 36
Atlanta 34
Curitiba 34
Jakarta 34
Ningbo 34
Haiphong 33
Lanzhou 33
Phoenix 33
Dhaka 32
Da Nang 31
Taizhou 31
Augusta 30
Brussels 30
Norwalk 29
Poplar 29
Porto Alegre 29
Baghdad 28
Boston 28
Manchester 28
Mexico City 28
Paris 28
Amsterdam 27
Pune 26
Totale 28.189
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 478
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 280
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 269
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 251
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 249
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 227
Pros-IT CNR: an Italian prostate cancer monitoring project 224
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 223
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 222
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 220
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 212
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 210
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 209
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 208
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 199
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 194
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 193
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 192
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 191
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 189
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 188
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 185
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 183
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 181
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 180
GUROPA survey: genito-urinary radiation oncology prescription attitudes 180
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 178
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 177
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 176
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 176
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 175
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 174
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 174
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 171
Role of external beam radiotherapy in the treatment of relapsing meningioma 171
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 170
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 169
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 166
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 166
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 165
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 165
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 163
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 163
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 162
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 162
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 162
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 160
From Molecular to Clinical Radiation Biology of Glioblastoma 159
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 158
Carboplatin (JM8), etoposide (VP16) and thoracic Irradiation for small cell lung cancer (S.C.L.C.): An evaluation of lung toxicity 158
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 158
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 158
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 157
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 157
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 156
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 156
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 155
"Radiotherapy versus combined modality in early stages", 154
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 154
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 153
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 152
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 152
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 151
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 150
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 150
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 150
Extreme hypofractionation for early prostate cancer: Biology meets technology 149
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 147
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 147
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 146
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. 145
Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series 143
Cetuximab and Radiation Therapy in Head and Neck Cancer 143
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 142
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 140
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 140
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma 140
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 140
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 140
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 140
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 140
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 139
A case report on how facing it problems: improving the reliability of a dicom router system through an affordable backup solution. 139
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 138
Information Retrieval in Medicine: an Extensive Experimental Study 137
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 136
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. 135
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 135
Postoperative radiotherapy after radical prostatectomy for prostate carcinoma: the experience of the Brescia Radium Institute. 134
18F-FDG-PET/CT in laryngeal cancer: Comparison with conventional imaging and prognostic role 134
Duration of androgen suppression in the treatment of prostate cancer 133
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 133
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 133
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 133
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 133
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 133
"CHEMOTHERAPY VERSUS RADIOTHERAPY IN EARLY-STAGE HODGKIN'S DISEASE: EVIDENCE OF A MORE DIFFICULT RESCUE FOR PATIENTS RELAPSED AFTER CHEMOTHERAPY" 132
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 132
Radiotherapy in case of locally advanced prostate cancer: long-term follow-up in 223 patients 130
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 130
Totale 16.911
Salva come PNG Salva come JPEG
Categoria #
all - tutte 224.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 224.099
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021200 0 0 0 0 0 0 0 0 0 0 0 200
2021/20222.644 143 488 47 104 44 137 113 211 155 305 229 668
2022/20232.483 449 133 72 160 173 638 8 236 305 143 83 83
2023/20242.909 131 48 253 129 119 529 91 116 826 67 81 519
2024/20256.457 44 80 35 801 819 557 714 184 557 511 1.296 859
2025/202612.876 1.172 1.913 1.118 2.165 1.102 753 1.756 454 839 961 480 163
Totale 44.494